Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 48, 2018 - Issue 1
177
Views
5
CrossRef citations to date
0
Altmetric
Pharmacogenetics

A high frequency missense SULT1B1 allelic variant (L145V) selectively expressed in African descendants exhibits altered kinetic properties

, , , &
Pages 79-88 | Received 24 Nov 2016, Accepted 11 Jan 2017, Published online: 05 Feb 2017

References

  • Allali-Hassani A, Pan PW, Dombrovski L, et al. (2007). Structural and chemical profiling of the human cytosolic sulfotransferases. PLoS Biol 5:e97
  • Bamber DE, Fryer AA, Strange RC, et al. (2001). Phenol sulphotransferase sult1a1*1 genotype is associated with reduced risk of colorectal cancer. Pharmacogenetics 11:679–85
  • Bird CE, Murphy J, Boroomand K, et al. (1978). Dehydroepiandrosterone: kinetics of metabolism in normal men and women. J Clin Endocrinol Metab 47:818–22
  • Blanchard RL. (2005). Nomenclature and molecular biology of the human sulfotransferase family. In: Pacifici GMC, Michael W.H., eds. Human cytosolic sulfotransferases. 1 ed. Boca Raton, FL: CRC Press. 1–26 p
  • Boccia S, Persiani R, La Torre G, et al. (2005). Sulfotransferase 1a1 polymorphism and gastric cancer risk: a pilot case-control study. Cancer Lett 229:235–43
  • Carlini EJ, Raftogianis RB, Wood TC, et al. (2001). Sulfation pharmacogenetics: Sult1a1 and sult1a2 allele frequencies in Caucasian, Chinese and African-American subjects. Pharmacogenetics 11:57–68
  • Cook I, Wang T, Almo SC, et al. (2013a). The gate that governs sulfotransferase selectivity. Biochemistry 52:415–24
  • Cook I, Wang T, Falany CN, et al. (2013b). High accuracy in silico sulfotransferase models. J Biol Chem 288:34494–501
  • Cook I, Wang T, Leyh TS. (2015). Sulfotransferase 1a1 substrate selectivity: a molecular clamp mechanism. Biochemistry 54:6114–22
  • Cook IT, Leyh TS, Kadlubar SA, et al. (2010). Structural rearrangement of sult2a1: effects on dehydroepiandrosterone and raloxifene sulfation. Horm Mol Biol Clin Investig 1:81–7
  • Dombrovski L, Dong A, Bochkarev A, et al. (2006). Crystal structures of human sulfotransferases sult1b1 and sult1c1 complexed with the cofactor product adenosine-3'-5'-diphosphate (pap). Proteins 64:1091–4
  • Edavana VK, Dhakal IB, Yu X, et al. (2012). Sulfation of 4-hydroxy toremifene: individual variability, isoform specificity, and contribution to toremifene pharmacogenomics. Drug Metab Dispos 40:1210–5
  • Falany CN, He D, Li L, et al. (2009). Regulation of hepatic sulfotransferase (sult) 1e1 expression and effects on estrogenic activity in cystic fibrosis (cf). J Steroid Biochem Mol Biol 114:113–9
  • Falany CN, Strom P, Swedmark S. (2005). Sulphation of o-desmethylnaproxen and related compounds by human cytosolic sulfotransferases. Br J Clin Pharmacol 60:632–40
  • Falany CN, Vazquez ME, Kalb JM. (1989). Purification and characterization of human liver dehydroepiandrosterone sulphotransferase. Biochem J 260:641–6
  • Falany CN, Xie X, Wang J, et al. (2000). Molecular cloning and expression of novel sulphotransferase-like cdnas from human and rat brain. Biochem J 346: 857–64
  • Fujita K, Nagata K, Ozawa S, et al. (1997). Molecular cloning and characterization of rat st1b1 and human st1b2 cdnas, encoding thyroid hormone sulfotransferases. J Biochem 122:1052–61
  • Glatt H. (2000). Sulfotransferases in the bioactivation of xenobiotics. Chem Biol Interact 129:141–70
  • Glatt H, Meinl W. (2004). Pharmacogenetics of soluble sulfotransferases (sults). Naunyn Schmiedebergs Arch Pharmacol 369:55–68
  • Lilla C, Risch A, Kropp S, et al. (2005). Sult1a1 genotype, active and passive smoking, and breast cancer risk by age 50 years in a german case-control study. Breast Cancer Res 7:R229–37
  • Meinl W, Glatt H. (2001). Structure and localization of the human sult1b1 gene: neighborhood to sult1e1 and a sult1d pseudogene. Biochem Biophys Res Commun 288:855–62
  • Meinl W, Tsoi C, Swedmark S, et al. (2013). Highly selective bioactivation of 1- and 2-hydroxy-3-methylcholanthrene to mutagens by individual human and other mammalian sulphotransferases expressed in salmonella typhimurium. Mutagenesis 28:609–19
  • Nowell S, Falany CN. (2006). Pharmacogenetics of human cytosolic sulfotransferases. Oncogene 25:1673–8
  • Pacifici GM, Giulianetti B, Quilici MC, et al. (1997). (-)-Salbutamol sulphation in the human liver and duodenal mucosa: interindividual variability. Xenobiotica 27:279–86
  • Pan PW, Tempel W, Dong A, Loppnau P, et al. 2008. Crystal structure of human cytosolic sulfotransferase sult1b1 in complex with pap and resveratrol
  • Raftogianis RB, Wood TC, Otterness DM, et al. (1997). Phenol sulfotransferase pharmacogenetics in humans: association of common sult1a1 alleles with TS PST phenotype. Biochem Biophys Res Commun 239:298–304
  • Raftogianis RB, Wood TC, Weinshilboum RM. (1999). Human phenol sulfotransferases sult1a2 and SULT1A1: genetic polymorphisms, allozyme properties, and human liver genotype-phenotype correlations. Biochem Pharmacol 58:605–16
  • Rens-Domiano SS, Roth JA. (1987). Inhibition of m and p phenol sulfotransferase by analogues of 3'-phosphoadenosine-5'-phosphosulfate. J Neurochem 48:1411–5
  • Riches Z, Stanley EL, Bloomer JC, et al. (2009). Quantitative evaluation of the expression and activity of five major sulfotransferases (sults) in human tissues: the sult “pie”. Drug Metab Dispos 37:2255–61
  • Rohn-Glowacki KJ, Falany CN. (2014). The potent inhibition of human cytosolic sulfotransferase 1a1 by 17α-ethinylestradiol is due to interactions with isoleucine 89 on loop 1. Horm Mol Biol Clin Investig 20:81–90
  • Sak K, Everaus H. (2016). Sulfotransferase 1a1 as a biomarker for susceptibility to carcinogenesis: from molecular genetics to the role of dietary flavonoids. Curr Drug Metab 17:528–41
  • Sherry ST, Ward MH, Kholodov M, et al. (2001). Dbsnp: the ncbi database of genetic variation. Nucleic Acids Res 29:308–11
  • Stenesh J. (1989). Dictionary of biochemistry and molecular biology. 2nd ed. New York: John Wiley & Sons
  • Teubner W, Meinl W, Florian S, et al. (2007). Identification and localization of soluble sulfotransferases in the human gastrointestinal tract. Biochem J 404:207–15
  • Thomae BA, Rifki OF, Theobald MA, et al. (2003). Human catecholamine sulfotransferase (sult1a3) pharmacogenetics: functional genetic polymorphism. J Neurochem 87:809–19
  • Tibbs ZE, Falany CN. (2015). Dimeric human sulfotransferase 1b1 displays cofactor-dependent subunit communication. Pharmacol Res Perspect 3:e00147
  • Tibbs ZE, Rohn-Glowacki KJ, Crittenden F, et al. (2015). Structural plasticity in the human cytosolic sulfotransferase dimer and its role in substrate selectivity and catalysis. Drug Metab Pharmacokinet 30:3–20
  • Ung D, Nagar S. (2007). Variable sulfation of dietary polyphenols by recombinant human sulfotransferase (sult) 1a1 genetic variants and sult1e1. Drug Metab Dispos 35:740–6
  • Wang J, Falany JL, Falany CN. (1998). Expression and characterization of a novel thyroid hormone-sulfating form of cytosolic sulfotransferase from human liver. Mol Pharmacol 53:274–82
  • Wang T, Cook I, Falany CN, et al. (2014). Paradigms of sulfotransferase catalysis: the mechanism of sult2a1. J Biol Chem 289:26474–80
  • Wood TC, Her C, Aksoy I, et al. (1996). Human dehydroepiandrosterone sulfotransferase pharmacogenetics: quantitative western analysis and gene sequence polymorphisms. J Steroid Biochem Mol Biol 59:467–78
  • Yang G, Gao YT, Cai QY, et al. (2005). Modifying effects of sulfotransferase 1a1 gene polymorphism on the association of breast cancer risk with body mass index or endogenous steroid hormones. Breast Cancer Res Treat 94:63–70
  • Zhang L, Huang M, Blair IA, et al. (2012). Detoxication of benzo[a]pyrene-7,8-dione by sulfotransferases (sults) in human lung cells. J Biol Chem 287:29909–20
  • Zheng Q, Sha X, Liu J, et al. (2010). Association of human cytochrome p450 1a1 (cyp1a1) and sulfotransferase 1a1 (sult1a1) polymorphisms with differential metabolism and cytotoxicity of aminoflavone. Mol Cancer Ther 9:2803–13

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.